Ipilimumab shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Ipilimumab
- Brand names
- Yervoy
- Class
- Auto-created by Health Canada backfill
Where Ipilimumab is in shortage
Why Ipilimumab is in shortage
- causes not stated by the regulator
Recent shortage history
- Canada: resolved (began 3 Oct 2025)
- Peru: resolved 9 Feb 2024 (began 9 Feb 2024)
Frequently asked questions
Is Ipilimumab currently in shortage?
Yes. As of the latest regulator updates, Ipilimumab has 1 active shortage notice across 1 country (Colombia). Status is refreshed daily from official regulatory sources.
Why is Ipilimumab in shortage?
Regulators attribute the current Ipilimumab shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Ipilimumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Ipilimumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.